Key facts
- It has raised $2.3M; the latest was Early Stage VC ($1.4M) in Jun 2025.
- Notable investors include Scale Good Fund, Amplify Capital, Engine Health Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Endor Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Endor Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Endor Health
Developer of a diabetes management platform designed to help people manage diabetes conditions effectively. The company's platform offers diabetes supplies, prescriptions, blood sugar tracking, insulin dose calculation, food and exercise logging, medication reminders, personalized insights, and recommendations, enabling people with diabetes to track their blood sugar levels and insulin doses accurately.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Toronto, Canada
- Founded
- 2023
- Employees
- 6
- Website
- endorhealth.com/
- Ownership
- Privately Held (backing)
Endor Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Endor Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Endor Health in its N-PORT filings yet. We sweep new filings monthly.